NYSE · CPAY

Corpay, Inc.

$385.05 +$14.47 (+3.90%) 1D Market open
Session Pulse Regular session 1 mentions on Fri No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$24.22B
Market cap
20.59×
P/E · TTM
$4.78B
Revenue · TTM
$1.18B
Net income
EPS · TTM $16.44
Dividend yield
Free cash flow $1.31B
Beta · 1Y 0.98
EBITDA · TTM $1.86B
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - CORPAY, INC. (0001175454) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 8
    The stock moved +12.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 8
  • Feb 5
    The stock moved +11.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$24.22B
Enterprise value$35.80B
Shares outstanding65.4M
52-wk range$252.84 – $382.78
Avg volume · 20D527.2K
Net cash −$11.58B
Book value / share$49.05
IndustryServices-Business Services, Nec
ExchangeNYSE
About Corpay, Inc.
IPO dateDec 15, 2010
Employees11800

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E20.59
P/S5.06
P/FCF18.48
EV/EBITDA19.27
EV/Sales7.48
Graham №$134.72

Profitability

Gross
Operating 35.9%
Net 24.6%
FCF 27.4%
ROE / ROIC 35.5% · 7.8%

Financial Health

Current ratio0.98
Quick ratio
Debt / equity4.02
Debt / EBITDA 7.60
Net cash −$11.58B
Working capital−$352.17M

Cash Flow · TTM

Operating CF $1.52B
Capex −$207.08M
Free cash flow $1.31B
Buybacks $1.51B
Dividends paid
Shareholder yield 6.2%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$134.72 vs $379.71
Trades 2.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings